DNA replication shows up everywhere on Step 1—not because you’ll be pipetting nucleotides, but because the exam loves the machinery: what each enzyme does, what happens when it fails, and which drugs/toxins exploit the process. If you can picture a replication fork and “assign jobs” to the proteins standing there, you’ll pick up easy points across biochem, micro, pharm, and genetics.
Big-picture definition (what you’re actually being tested on)
DNA replication is semi-conservative, bidirectional, and proceeds 5′ → 3′ (because DNA polymerases add nucleotides to a free 3′-OH). It occurs during the S phase and requires:
- A template
- A primer (free 3′-OH)
- dNTPs
- Multiple enzymes/proteins to unwind, stabilize, start, extend, and seal DNA
Core Step 1 theme: most questions boil down to “Which enzyme is defective/inhibited?” or “Which strand is being made continuously?”
First Aid cross-ref: DNA replication & repair; DNA polymerases; antineoplastics/antibiotics that inhibit nucleic acid synthesis (Biochemistry + Pharmacology sections).
The replication fork: your mental map
At the fork, you have:
- Helicase: separates the strands
- Single-strand binding proteins (SSB): keep strands apart
- Topoisomerases: relieve supercoiling ahead of the fork
- Primase: lays down RNA primers
- DNA polymerases: extend DNA
- Sliding clamp: keeps polymerase attached (processivity)
- RNase H / exonucleases: remove primers (in eukaryotes)
- DNA ligase: seals nicks between fragments
Leading vs lagging strand (high-yield)
| Feature | Leading strand | Lagging strand |
|---|---|---|
| Direction relative to fork | Toward the fork | Away from the fork |
| Synthesis | Continuous | Discontinuous |
| Key concept | One primer | Many primers → Okazaki fragments |
| “Buzzword” | “Continuous” | “Okazaki fragments” |
Common trap: Both strands are synthesized 5′ → 3′. The difference is continuous vs discontinuous.
Enzyme-by-enzyme: what it does + how Step 1 tests it
1) Helicase
Job: Unwinds DNA (breaks hydrogen bonds).
- Prokaryote: DnaB helicase
- Eukaryote: MCM complex (often not tested by name)
Testable idea: if helicase is impaired → fork stalls → replication stress → DNA damage signaling.
2) Single-strand binding proteins (SSB)
Job: Stabilize unwound ssDNA and prevent re-annealing.
- Prokaryote: SSB
- Eukaryote: RPA (replication protein A)
Testable idea: without SSB/RPA, ssDNA can form hairpins or re-anneal, slowing replication.
3) Topoisomerases (aka DNA gyrase in bacteria)
Job: Relieve positive supercoils ahead of fork by cutting and resealing DNA.
| Enzyme | Cut type | High-yield inhibitors/toxins |
|---|---|---|
| Topoisomerase I | Single-strand nicks | (Less commonly tested in Step 1 pharm; key concept is “single-strand”) |
| Topoisomerase II | Double-strand breaks | Etoposide, teniposide (euk) |
| Bacterial DNA gyrase (Topo II) | Double-strand breaks | Fluoroquinolones (ciprofloxacin, levofloxacin), novobiocin |
Classic Step 1 stem: “Antibiotic inhibits DNA gyrase” → fluoroquinolones.
First Aid cross-ref: Antibiotics—fluoroquinolones; Antineoplastics—etoposide/teniposide; DNA replication enzymes.
4) Primase (lays RNA primers)
Job: Synthesizes short RNA primers so DNA polymerase has a 3′-OH to extend.
- Prokaryotes: primase makes primers for both leading and lagging strands (lagging needs many).
- Eukaryotes: primase is part of DNA polymerase α complex.
Why it’s tested: DNA polymerases generally can’t start de novo; they extend only.
5) DNA polymerases (the core high-yield content)
Prokaryotic DNA polymerases (Step 1 favorites)
| Polymerase | Main job | 3′→5′ proofreading? | 5′→3′ exonuclease? |
|---|---|---|---|
| DNA pol III | Main replication polymerase | Yes | No |
| DNA pol I | Remove RNA primers + fill gaps | Yes | Yes (removes primer) |
How tested:
- “Enzyme removes RNA primer in bacteria” → DNA pol I via 5′ → 3′ exonuclease
- “Main replicative polymerase in bacteria” → DNA pol III
Eukaryotic DNA polymerases (know the triad)
| Polymerase | Main job | High-yield note |
|---|---|---|
| Pol α | Initiation: primase activity + short DNA | Starts Okazaki fragments (hands off to δ) |
| Pol δ | Lagging strand synthesis | Extends Okazaki fragments |
| Pol ε | Leading strand synthesis | Continuous synthesis |
All major replicative eukaryotic polymerases have 3′ → 5′ proofreading.
Common question style: mismatch rate increases when proofreading impaired → think 3′ → 5′ exonuclease dysfunction.
6) Sliding clamp (processivity factor)
Job: Prevents polymerase from falling off DNA.
- Prokaryote clamp: β-clamp
- Eukaryote clamp: PCNA
Testable idea: decreased processivity → short DNA fragments, frequent dissociation.
7) Primer removal & gap filling (eukaryotes vs prokaryotes)
- Prokaryotes: DNA pol I removes RNA primers (5′→3′ exonuclease) and fills gaps.
- Eukaryotes: RNase H removes RNA primer; FEN1 removes remaining flap; DNA pol δ fills; ligase seals.
Step 1 angle: if a question specifies eukaryotic primer removal, don’t reflexively answer “DNA pol I” (that’s bacterial).
8) DNA ligase
Job: Seals nicks between Okazaki fragments (forms phosphodiester bond).
- Requires ATP in eukaryotes
- Often taught as using ATP (vs bacterial ligase can use NAD⁺—less commonly tested)
Clinical pharm tie-in: impaired ligase → persistent nicks → genome instability.
One-minute “replication fork story” (use this as a test-day script)
- Topoisomerase relieves supercoils ahead of the fork
- Helicase opens the helix
- SSB/RPA stabilizes ssDNA
- Primase lays primers (many on lagging)
- DNA polymerase extends 5′→3′ with 3′→5′ proofreading
- Lagging strand makes Okazaki fragments
- Primers removed (pol I in bacteria; RNase H/FEN1 in euks)
- Ligase seals the last nick
If you can recite that, most “replication machinery” questions become straightforward.
Pathophysiology: what happens when replication goes wrong?
Replication stress → fork stalling → double-strand breaks → checkpoint activation (p53 pathways) → apoptosis or mutations.
High-yield failure modes:
- Loss of proofreading → increased point mutations
- Defective mismatch repair (post-replication) → microsatellite instability (ties to colon cancer syndromes)
- Defective telomere maintenance → progressive shortening → cell senescence/apoptosis (or immortality in cancers)
Even if the question is “replication machinery,” the downstream disease association might be in DNA repair or cell cycle checkpoints.
First Aid cross-ref: DNA repair (MMR/NER/BER/HR/NHEJ), tumor suppressors, cell cycle, oncology.
Clinical presentation: how this shows up in vignettes
Replication machinery problems rarely present as “I have a helicase deficiency.” Instead, you see:
- Cancer predisposition (genomic instability)
- Bone marrow suppression from chemo targeting S-phase
- Infections treated with agents targeting bacterial replication
- Developmental syndromes with DNA repair/replication stress phenotypes (short stature, photosensitivity, immunodeficiency depending on pathway)
Diagnosis: what clues point to replication/replication-associated problems?
Lab/board-style clues
- S-phase specificity in a drug question → think DNA synthesis inhibitors
- Microsatellite instability → mismatch repair defect (replication-associated repair)
- Pancytopenia after chemo → off-target killing of rapidly dividing cells
- Bacterial enzyme target (gyrase) → fluoroquinolone mechanism
Treatment & pharmacology: the HY inhibitors tied to replication
Antibacterials
| Drug class | Target | Mechanism | Board clue |
|---|---|---|---|
| Fluoroquinolones | DNA gyrase (Topo II), Topo IV | Block supercoil relaxation/decatenation | Tendinopathy, QT prolongation, cartilage toxicity |
| Metronidazole | DNA (anaerobes/protozoa) | Free radical damage | Disulfiram-like, metallic taste |
| Rifampin (RNA, not DNA) | DNA-dependent RNA polymerase | ↓ RNA synthesis | Orange fluids, CYP inducer |
(They love mixing DNA replication with transcription inhibitors—watch what enzyme is named.)
Antineoplastics (S-phase emphasis)
| Drug | Category | High-yield mechanism |
|---|---|---|
| Cytarabine | Pyrimidine analog | Inhibits DNA polymerase |
| 5-FU / Capecitabine | Pyrimidine analog | Inhibits thymidylate synthase → ↓ dTMP |
| Methotrexate | Folate analog | Inhibits DHFR → ↓ dTMP (and purines) |
| Hydroxyurea | Ribonucleotide reductase inhibitor | ↓ deoxyribonucleotides |
| Etoposide/Teniposide | Topo II inhibitors | Double-strand breaks |
| Irinotecan/Topotecan | Topo I inhibitors | Single-strand breaks |
High-yield integration: If the question says “breaks prevented from being resealed” → think topoisomerase inhibitors.
High-yield associations & “don’t-miss” facts (Step 1 quick hits)
Absolute must-know bullets
- DNA synthesis is 5′ → 3′; proofreading is 3′ → 5′ exonuclease.
- Okazaki fragments happen on the lagging strand.
- Primase makes RNA primers (needed for DNA pol to start).
- Bacteria:
- Pol III replicates
- Pol I removes primers (5′ → 3′ exonuclease)
- Topoisomerase/gyrase relieves supercoiling; fluoroquinolones inhibit bacterial DNA gyrase.
- Ligase seals nicks (esp. between Okazaki fragments).
“Classic wrong answer” pitfalls
- Saying proofreading is 5′ → 3′ (it’s 3′ → 5′).
- Saying the lagging strand is made 3′ → 5′ (it isn’t; it’s still 5′ → 3′, just discontinuous).
- Mixing bacterial pol I primer removal with eukaryotic RNase H/FEN1.
Mini-table: replication vs repair (because NBME loves the overlap)
| Process | When | Goal | Example pathology |
|---|---|---|---|
| Replication | S-phase | Copy genome | Polymerase proofreading defects → ↑ mutations |
| Mismatch repair (MMR) | Post-replication | Fix base mismatches | Lynch syndrome (MSI) |
| NER/BER | Any time | Remove damaged bases | Xeroderma pigmentosum (NER) |
| DSB repair (HR/NHEJ) | Any time | Fix double-strand breaks | BRCA-related issues (HR) |
How to lock this down for exams (fast study plan)
- Draw one replication fork and label: helicase, SSB, topo, primase, pol, clamp, ligase.
- Memorize the bacterial pol I vs pol III distinction.
- Anchor drug mechanisms to enzymes:
- Fluoroquinolones → gyrase (Topo II)
- Etoposide → Topo II
- Irinotecan/topotecan → Topo I
- Practice identifying leading vs lagging from strand polarity in diagrams.
First Aid cross-references (where this lives conceptually)
- Biochemistry: DNA replication enzymes; polymerase directionality; Okazaki fragments; telomeres (often adjacent)
- Biochemistry/Genetics: DNA repair pathways (MMR/NER/BER/HR/NHEJ)
- Pharmacology: Antineoplastics affecting S phase; antibiotics targeting DNA/RNA synthesis
- Microbiology: Fluoroquinolone mechanism (gyrase/topo)
(Section titles vary by edition, but these topics cluster consistently.)